<DOC>
	<DOC>NCT00782938</DOC>
	<brief_summary>Drugs with anticholinergic potential increase the risk of postoperative transient and persistent cognitive dysfunction especially in cardiac patients. The investigators main goal is to identify preoperative risk factors and to monitor postoperative patients' state in relation to SAA activity and bilateral BIS-EEG changes.</brief_summary>
	<brief_title>The Role of Serum Anticholinergic Activity in ACVB Patients</brief_title>
	<detailed_description />
	<mesh_term>Cholinergic Antagonists</mesh_term>
	<criteria>written compliance to the study participation a good knowledge in German speech no red/ green blindness no previous neurological and/or psychiatric illness good ability to see and to hear MiniMentalStateExamination (MMSE) better than 25 points no written compliance to the study participation bad knowledge in German speech red/ green blindness previous neurological and/or psychiatric illness no ability to see and to hear MiniMentalStateExamination (MMSE) lower than 25 points</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>